Literature DB >> 7495840

Proton/peptide cotransporter (PEPT 2) from human kidney: functional characterization and chromosomal localization.

S Ramamoorthy1, W Liu, Y Y Ma, T L Yang-Feng, V Ganapathy, F H Leibach.   

Abstract

We report here on the functional characterization of the H+/peptide cotransporter PEPT 2 cloned from human kidney and on the chromosomal localization of the PEPT 2 gene. PEPT 2, when functionally expressed in HeLa cells, induces the transport of the neutral dipeptide glycylsarcosine. The induced transport activity is markedly influenced by extracellular pH. The optimum pH for the transport process is 6.0-7.0. Kinetic analysis has revealed that PEPT 2 is a high-affinity transporter, the Michaelis-Menten constant for glycylsarcosine being 74 +/- 14 microM. The human intestinal H+/peptide cotransporter PEPT 1 has 4-fold less affinity for the dipeptide under identical experimental conditions. Studies with other chemically diverse dipeptides have established that PEPT 2 possesses higher affinity than PEPT 1 not only for neutral peptides but also for peptides consisting of anionic and/or cationic amino acids. Somatic cell hybrid analysis and in situ hybridization have shown that the gene encoding PEPT 2 maps to human chromosome 3q13.3-q21.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495840     DOI: 10.1016/0005-2736(95)00178-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition.

Authors:  T Terada; H Saito; K Sawada; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Authors:  R Heidemann; C Zhang; H Qi; J Larrick Rule; C Rozales; S Park; S Chuppa; M Ray; J Michaels; K Konstantinov; D Naveh
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

Review 3.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

Review 4.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

5.  Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.

Authors:  Feifeng Song; Yongjun Hu; Huidi Jiang; David E Smith
Journal:  Drug Metab Dispos       Date:  2016-11-11       Impact factor: 3.922

6.  δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2*2 haplotype may differentially mediate lead exposure in male children.

Authors:  Christina Sobin; Natali Parisi; Tanner Schaub; Marisela Gutierrez; Alma X Ortega
Journal:  Arch Environ Contam Toxicol       Date:  2011-02-16       Impact factor: 2.804

7.  δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2*2 haplotype (hPEPT2*2) differently influence neurobehavior in low-level lead exposed children.

Authors:  Christina Sobin; Mayra Gisel Flores-Montoya; Marisela Gutierrez; Natali Parisi; Tanner Schaub
Journal:  Neurotoxicol Teratol       Date:  2014-12-13       Impact factor: 3.763

Review 8.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

9.  Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure.

Authors:  Christina Sobin; Marisela Gutierrez; Heather Alterio
Journal:  Neurotoxicology       Date:  2009-08-31       Impact factor: 4.294

Review 10.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.